GGrantIndex
Sort

16,300 grants matching fatty liver disease

Regulation of Glycogen in Health and Disease

$483,482
Alan R. Saltiel · University Of California, San Diego · R01 · FY2019 · DK

Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy

$483,380
T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK

Dietary Factors in the Pathogenesis of Steatohepatitis

$483,372
Jacquelyn J. Maher · University Of California, San Francisco · R01 · FY2011 · DK

Control of glucose homeostasis through the insulin-independent Isthmin pathway

$483,367
Katrin Jennifer Svensson · Stanford University · R01 · FY2020 · DK

Improving treatment of HER2+ breast cancer brain metastasis by targeting lipid metabolism

$483,164
Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2021 · CA

Ethnicity and fat deposition in obesity-related disease in youth

$483,080
Vicente Gilsanze · University Of Southern California · P60 · FY2007 · MD

3D Circadian Enhancer-Promoter Interactions Mediated by ESRRG in NAFLD-to-HCC Progression

$483,077
Dongyin Guan · Baylor College Of Medicine · R37 · FY2025 · CA

Does traffic-related air pollution accelerate the development of the metabolic syndrome by impairing the resolution of neurogenic inflammation?

$483,000
Ameer Taha · University Of California At Davis · R56 · FY2025 · ES

Scavenger Receptors: Ligand Binding and Pathophysiology

$482,987
Monty Krieger · Massachusetts Institute Of Technology · R01 · FY2008 · HL

Regulation of Hepatic Fuel Fluxes by the Mitochondrial Dicarboxylate Carrier

$482,871
Eric B Taylor · University Of Iowa · R01 · FY2025 · DK

CETP and Sex-Differences in Metabolic and Cardiovascular Disease

$482,584
John Micheal Stafford · Vanderbilt University Medical Center · R01 · FY2022 · HL

CETP and Sex-Differences in Metabolic and Cardiovascular Disease

$482,579
John Micheal Stafford · Vanderbilt University Medical Center · R01 · FY2021 · HL

Mechanisms and Functions of Core-induced Lipid Droplet Accumulation in Hepatitis

$482,500
Melanie Maria Ott · J. David Gladstone Institutes · R56 · FY2010 · AI

The molecular mechanisms of nutrient- and stress-dependent mTORC1 regulation mediated by human Sestrin2.

$482,475
Uhn-Soo Cho · University Of Michigan At Ann Arbor · R01 · FY2019 · DK

Cross-regulation of Immunometabolism and Circadian Pathways in Obesity Pathophysiology

$482,388
Joseph T Bass · Northwestern University At Chicago · R01 · FY2023 · DK

Cross-regulation of Immunometabolism and Circadian Pathways in Obesity Pathophysiology

$482,388
Joseph T Bass · Northwestern University At Chicago · R01 · FY2022 · DK

A novel role of cholesterol and SR-BI in adipocyte biology

$482,342
Chieko Mineo · Ut Southwestern Medical Center · R01 · FY2025 · DK

Regulation of Glycogen in Health and Disease

$482,340
Alan R. Saltiel · University Of California, San Diego · R01 · FY2020 · DK

The Inflammatory Response Pathway in the Etiology of Polycystic Ovary Syndrome

$482,269
Margrit Urbanek · Northwestern University At Chicago · R01 · FY2009 · HD

Advanced C-arm imaging platform for histotripsy treatment of liver tumors

$482,241
Paul F Laeseke · University Of Wisconsin-Madison · R01 · FY2022 · EB

Improving Diagnostic Safety through STeatosis Identification, Risk stratification, and Referral in the ED (STIRRED)

$482,197
Amy V Kontrick · Northwestern University At Chicago · R01 · FY2024 · HS

NAFLD Improvement after Bariatric Surgery: The role of bile acid signaling

$482,124
Rohit Kohli · Children'S Hospital Of Los Angeles · R01 · FY2019 · DK

NAFLD Improvement after Bariatric Surgery: The role of bile acid signaling

$482,124
Rohit Kohli · Children'S Hospital Of Los Angeles · R01 · FY2017 · DK

Renal Disposition in NASH

$482,102
Nathan J Cherrington · University Of Arizona · R01 · FY2020 · ES

Renal Disposition in NASH

$482,102
Nathan J Cherrington · University Of Arizona · R01 · FY2023 · ES